Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ovidiu C Andronesi, Ph.D., M.D.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA211080 (ANDRONESI, OVIDIU C) Feb 1, 2017 - Jan 31, 2022
    NIH/NCI
    Development of whole-brain in vivo 2HG imaging for precision medicine in mutant IDH glioma
    Role: Principal Investigator
  2. K22CA178269 (ANDRONESI, OVIDIU C) Jul 8, 2013 - Nov 30, 2016
    NIH/NCI
    Quantify treatment response in IDH1 mutant glioma patients with metabolic MRI
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Torrado-Carvajal A, Albrecht DS, Lee J, Andronesi OC, Ratai EM, Napadow V, Loggia ML. Inpainting as a Technique for Estimation of Missing Voxels in Brain Imaging. Ann Biomed Eng. 2020 Jul 14. PMID: 32632531.
    Citations:    
  2. Maudsley AA, Andronesi OC, Barker PB, Bizzi A, Bogner W, Henning A, Nelson SJ, Posse S, Shungu DC, Soher BJ. Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations. NMR Biomed. 2020 Apr 29; e4309. PMID: 32350978.
    Citations:    
  3. Ma RE, Murdoch JB, Bogner W, Andronesi O, Dydak U. Atlas-based GABA mapping with 3D MEGA-MRSI: Cross-correlation to single-voxel MRS. NMR Biomed. 2020 Feb 20; e4275. PMID: 32078755.
    Citations:    
  4. Li X, Strasser B, Jafari-Khouzani K, Thapa B, Small J, Cahill DP, Dietrich J, Batchelor TT, Andronesi OC. Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas. Radiology. 2020 03; 294(3):589-597. PMID: 31909698.
    Citations:    
  5. Richter C, Andronesi OC, Borra RJH, Voigt F, Löck S, Duda DG, Guimaraes AR, Hong TS, Bortfeld TR, Seco J. Inter-patient variations of radiation-induced normal-tissue changes in Gd-EOB-DTPA-enhanced hepatic MRI scans during fractionated proton therapy. Clin Transl Radiat Oncol. 2019 Sep; 18:113-119. PMID: 31341986.
    Citations:    
  6. Wilson M, Andronesi O, Barker PB, Bartha R, Bizzi A, Bolan PJ, Brindle KM, Choi IY, Cudalbu C, Dydak U, Emir UE, Gonzalez RG, Gruber S, Gruetter R, Gupta RK, Heerschap A, Henning A, Hetherington HP, Huppi PS, Hurd RE, Kantarci K, Kauppinen RA, Klomp DWJ, Kreis R, Kruiskamp MJ, Leach MO, Lin AP, Luijten PR, Marjanska M, Maudsley AA, Meyerhoff DJ, Mountford CE, Mullins PG, Murdoch JB, Nelson SJ, Noeske R, Öz G, Pan JW, Peet AC, Poptani H, Posse S, Ratai EM, Salibi N, Scheenen TWJ, Smith ICP, Soher BJ, Tkác I, Vigneron DB, Howe FA. Methodological consensus on clinical proton MRS of the brain: Review and recommendations. Magn Reson Med. 2019 08; 82(2):527-550. PMID: 30919510.
    Citations:    
  7. Nicholson K, Chan J, Macklin EA, Levine-Weinberg M, Breen C, Bakshi R, Grasso DL, Wills AM, Jahandideh S, Taylor AA, Beaulieu D, Ennist DL, Andronesi O, Ratai EM, Schwarzschild MA, Cudkowicz M, Paganoni S. Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2018 Dec; 5(12):1522-1533. PMID: 30564619.
    Citations:    
  8. Moser P, Hingerl L, Strasser B, Považan M, Hangel G, Andronesi OC, van der Kouwe A, Gruber S, Trattnig S, Bogner W. Whole-slice mapping of GABA and GABA+ at 7T via adiabatic MEGA-editing, real-time instability correction, and concentric circle readout. Neuroimage. 2019 01 01; 184:475-489. PMID: 30243974.
    Citations:    Fields:    
  9. Andronesi OC. Precision oncology in the era of radiogenomics: the case of D-2HG as an imaging biomarker for mutant IDH gliomas. Neuro Oncol. 2018 06 18; 20(7):865-867. PMID: 29924369.
    Citations:    Fields:    
  10. Ratai EM, Zhang Z, Fink J, Muzi M, Hanna L, Greco E, Richards T, Kim D, Andronesi OC, Mintz A, Kostakoglu L, Prah M, Ellingson B, Schmainda K, Sorensen G, Barboriak D, Mankoff D, Gerstner ER. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy. PLoS One. 2018; 13(6):e0198548. PMID: 29902200.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  11. Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT. Bone marrow drives central nervous system regeneration after radiation injury. J Clin Invest. 2018 06 01; 128(6):2651. PMID: 29856368.
    Citations:    Fields:    
  12. Andronesi OC, Arrillaga-Romany IC, Ly KI, Bogner W, Ratai EM, Reitz K, Iafrate AJ, Dietrich J, Gerstner ER, Chi AS, Rosen BR, Wen PY, Cahill DP, Batchelor TT. Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. Nat Commun. 2018 04 16; 9(1):1474. PMID: 29662077.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  13. Kickingereder P, Andronesi OC. Radiomics, Metabolic, and Molecular MRI for Brain Tumors. Semin Neurol. 2018 02; 38(1):32-40. PMID: 29548050.
    Citations: 2     Fields:    Translation:Humans
  14. Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT. Bone marrow drives central nervous system regeneration after radiation injury. J Clin Invest. 2018 01 02; 128(1):281-293. PMID: 29202481.
    Citations: 2     Fields:    
  15. Miller JJ, Shih HA, Andronesi OC, Cahill DP. Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications. Cancer. 2017 Dec 01; 123(23):4535-4546. PMID: 28980701.
    Citations: 8     Fields:    Translation:Humans
  16. Heckova E, Považan M, Strasser B, Krumpolec P, Hnilicová P, Hangel GJ, Moser PA, Andronesi OC, van der Kouwe AJ, Valkovic P, Ukropcova B, Trattnig S, Bogner W. Real-time Correction of Motion and Imager Instability Artifacts during 3D ?-Aminobutyric Acid-edited MR Spectroscopic Imaging. Radiology. 2018 02; 286(2):666-675. PMID: 28957645.
    Citations:    Fields:    Translation:Humans
  17. Andronesi OC, Esmaeili M, Borra RJH, Emblem K, Gerstner ER, Pinho MC, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Ivy SP, Wen PY, Duda DG, Jain R, Rosen BR, Sorensen GA, Batchelor TT. Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival. NPJ Precis Oncol. 2017; 1. PMID: 29202103.
    Citations:    
  18. Bogner W, Hangel G, Esmaeili M, Andronesi OC. 1D-spectral editing and 2D multispectral in vivo1H-MRS and 1H-MRSI - Methods and applications. Anal Biochem. 2017 07 15; 529:48-64. PMID: 28034791.
    Citations: 3     Fields:    Translation:HumansAnimals
  19. Valkovic L, Chmelík M, Meyerspeer M, Gagoski B, Rodgers CT, Krššák M, Andronesi OC, Trattnig S, Bogner W. Dynamic 31 P-MRSI using spiral spectroscopic imaging can map mitochondrial capacity in muscles of the human calf during plantar flexion exercise at 7 T. NMR Biomed. 2016 12; 29(12):1825-1834. PMID: 27862510.
    Citations: 11     Fields:    Translation:HumansCells
  20. Hnilicová P, Považan M, Strasser B, Andronesi OC, Gajdošík M, Dydak U, Ukropec J, Dobrota D, Trattnig S, Bogner W. Spatial variability and reproducibility of GABA-edited MEGA-LASER 3D-MRSI in the brain at 3 T. NMR Biomed. 2016 11; 29(11):1656-1665. PMID: 27717093.
    Citations: 2     Fields:    Translation:Humans
  21. Jafari-Khouzani K, Loebel F, Bogner W, Rapalino O, Gonzalez GR, Gerstner E, Chi AS, Batchelor TT, Rosen BR, Unkelbach J, Shih HA, Cahill DP, Andronesi OC. Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients. Neuro Oncol. 2016 11; 18(11):1569-1578. PMID: 27382115.
    Citations: 5     Fields:    Translation:Humans
  22. Esmaeili M, Bathen TF, Rosen BR, Andronesi OC. Three-dimensional MR spectroscopic imaging using adiabatic spin echo and hypergeometric dual-band suppression for metabolic mapping over the entire brain. Magn Reson Med. 2017 02; 77(2):490-497. PMID: 26840906.
    Citations:    Fields:    Translation:Humans
  23. Andronesi OC, Loebel F, Bogner W, Marjanska M, Vander Heiden MG, Iafrate AJ, Dietrich J, Batchelor TT, Gerstner ER, Kaelin WG, Chi AS, Rosen BR, Cahill DP. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. Clin Cancer Res. 2016 Apr 01; 22(7):1632-41. PMID: 26534967.
    Citations: 24     Fields:    Translation:Humans
  24. Schirda CV, Zhao T, Andronesi OC, Lee Y, Pan JW, Mountz JM, Hetherington HP, Boada FE. In vivo brain rosette spectroscopic imaging (RSI) with LASER excitation, constant gradient strength readout, and automated LCModel quantification for all voxels. Magn Reson Med. 2016 08; 76(2):380-90. PMID: 26308482.
    Citations: 2     Fields:    Translation:Humans
  25. Bogner W, Gagoski B, Hess AT, Bhat H, Tisdall MD, van der Kouwe AJW, Strasser B, Marjanska M, Trattnig S, Grant E, Rosen B, Andronesi OC. 3D GABA imaging with real-time motion correction, shim update and reacquisition of adiabatic spiral MRSI. Neuroimage. 2014 Dec; 103:290-302. PMID: 25255945.
    Citations: 20     Fields:    Translation:Humans
  26. Kalpathy-Cramer J, Gerstner ER, Emblem KE, Andronesi O, Rosen B. Advanced magnetic resonance imaging of the physical processes in human glioblastoma. Cancer Res. 2014 Sep 01; 74(17):4622-4637. PMID: 25183787.
    Citations: 28     Fields:    Translation:Humans
  27. Loebel F, Cahill DP, Bogner W, Marjanska M, Gerstner E, Batchelor T, Rosen BR, Chi AS, Andronesi OC. Sherry apple resident travel scholarship 194 assessment of treatment response in isocitrate dehydrogenase-mutant gliomas by quantification of 2-hydroxyglutarate with in vivo 3-dimensional magnetic resonance spectroscopy. Neurosurgery. 2014 Aug; 61 Suppl 1:224. PMID: 25032645.
    Citations:    
  28. Andronesi OC, Bhat H, Reuter M, Mukherjee S, Caravan P, Rosen BR. Whole brain mapping of water pools and molecular dynamics with rotating frame MR relaxation using gradient modulated low-power adiabatic pulses. Neuroimage. 2014 Apr 01; 89:92-109. PMID: 24345390.
    Citations: 3     Fields:    Translation:HumansCells
  29. Bogner W, Hess AT, Gagoski B, Tisdall MD, van der Kouwe AJ, Trattnig S, Rosen B, Andronesi OC. Real-time motion- and B0-correction for LASER-localized spiral-accelerated 3D-MRSI of the brain at 3T. Neuroimage. 2014 03; 88:22-31. PMID: 24201013.
    Citations: 12     Fields:    Translation:Humans
  30. Eichner C, Jafari-Khouzani K, Cauley S, Bhat H, Polaskova P, Andronesi OC, Rapalino O, Turner R, Wald LL, Stufflebeam S, Setsompop K. Slice accelerated gradient-echo spin-echo dynamic susceptibility contrast imaging with blipped CAIPI for increased slice coverage. Magn Reson Med. 2014 Sep; 72(3):770-8. PMID: 24285593.
    Citations: 11     Fields:    Translation:Humans
  31. Andronesi OC, Rapalino O, Gerstner E, Chi A, Batchelor TT, Cahill DP, Sorensen AG, Rosen BR. Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. J Clin Invest. 2013 Sep; 123(9):3659-63. PMID: 23999439.
    Citations: 39     Fields:    Translation:Humans
  32. Yuan Y, Andronesi OC, Bortfeld TR, Richter C, Wolf R, Guimaraes AR, Hong TS, Seco J. Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients. Radiother Oncol. 2013 Mar; 106(3):378-82. PMID: 23473960.
    Citations: 6     Fields:    Translation:Humans
  33. Dunn GP, Andronesi OC, Cahill DP. From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma. Neurosurg Focus. 2013 Feb; 34(2):E2. PMID: 23373447.
    Citations: 13     Fields:    Translation:HumansAnimals
  34. Metsis V, Huang H, Andronesi OC, Makedon F, Tzika A. Heterogeneous data fusion for brain tumor classification. Oncol Rep. 2012 Oct; 28(4):1413-6. PMID: 22842996.
    Citations: 3     Fields:    Translation:Humans
  35. Andronesi OC, Kim GS, Gerstner E, Batchelor T, Tzika AA, Fantin VR, Vander Heiden MG, Sorensen AG. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med. 2012 Jan 11; 4(116):116ra4. PMID: 22238332.
    Citations: 102     Fields:    Translation:Humans
  36. Andronesi OC, Gagoski BA, Sorensen AG. Neurologic 3D MR spectroscopic imaging with low-power adiabatic pulses and fast spiral acquisition. Radiology. 2012 Feb; 262(2):647-61. PMID: 22187628.
    Citations: 20     Fields:    Translation:Humans
  37. Hess AT, Andronesi OC, Tisdall MD, Sorensen AG, van der Kouwe AJ, Meintjes EM. Real-time motion and B0 correction for localized adiabatic selective refocusing (LASER) MRSI using echo planar imaging volumetric navigators. NMR Biomed. 2012 Feb; 25(2):347-58. PMID: 21796711.
    Citations: 8     Fields:    Translation:Humans
  38. Andronesi OC, Gagoski BA, Adalsteinsson E, Sorensen AG. Correlation chemical shift imaging with low-power adiabatic pulses and constant-density spiral trajectories. NMR Biomed. 2012 Feb; 25(2):195-209. PMID: 21774010.
    Citations: 4     Fields:    Translation:Humans
  39. Kim H, Catana C, Ratai EM, Andronesi OC, Jennings DL, Batchelor TT, Jain RK, Sorensen AG. Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma. Cancer Res. 2011 Jun 01; 71(11):3745-52. PMID: 21507932.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  40. Bogner W, Chmelik M, Andronesi OC, Sorensen AG, Trattnig S, Gruber S. In vivo 31P spectroscopy by fully adiabatic extended image selected in vivo spectroscopy: a comparison between 3 T and 7 T. Magn Reson Med. 2011 Oct; 66(4):923-30. PMID: 21446033.
    Citations: 14     Fields:    Translation:Humans
  41. Hess AT, Tisdall MD, Andronesi OC, Meintjes EM, van der Kouwe AJ. Real-time motion and B0 corrected single voxel spectroscopy using volumetric navigators. Magn Reson Med. 2011 Aug; 66(2):314-23. PMID: 21381101.
    Citations: 33     Fields:    Translation:Humans
  42. Ramadan S, Andronesi OC, Stanwell P, Lin AP, Sorensen AG, Mountford CE. Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma. Radiology. 2011 May; 259(2):540-9. PMID: 21357517.
    Citations: 8     Fields:    Translation:Humans
  43. Astrakas L, Blekas KD, Constantinou C, Andronesi OC, Mindrinos MN, Likas AC, Rahme LG, Black PM, Marcus KJ, Tzika AA. Combining magnetic resonance spectroscopy and molecular genomics offers better accuracy in brain tumor typing and prediction of survival than either methodology alone. Int J Oncol. 2011 Apr; 38(4):1113-27. PMID: 21274507.
    Citations: 3     Fields:    Translation:Humans
  44. di Tomaso E, Snuderl M, Kamoun WS, Duda DG, Auluck PK, Fazlollahi L, Andronesi OC, Frosch MP, Wen PY, Plotkin SR, Hedley-Whyte ET, Sorensen AG, Batchelor TT, Jain RK. Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Res. 2011 Jan 01; 71(1):19-28. PMID: 21199795.
    Citations: 73     Fields:    Translation:Humans
  45. Andronesi OC, Mintzopoulos D, Righi V, Psychogios N, Kesarwani M, He J, Yasuhara S, Dai G, Rahme LG, Tzika AA. Combined off-resonance imaging and T2 relaxation in the rotating frame for positive contrast MR imaging of infection in a murine burn model. J Magn Reson Imaging. 2010 Nov; 32(5):1172-83. PMID: 21031524.
    Citations: 2     Fields:    Translation:AnimalsCells
  46. Andronesi OC, Ramadan S, Mountford CE, Sorensen AG. Low-power adiabatic sequences for in vivo localized two-dimensional chemical shift correlated MR spectroscopy. Magn Reson Med. 2010 Dec; 64(6):1542-56. PMID: 20890988.
    Citations: 7     Fields:    Translation:Humans
  47. Righi V, Andronesi OC, Mintzopoulos D, Black PM, Tzika AA. High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors. Int J Oncol. 2010 Feb; 36(2):301-6. PMID: 20043062.
    Citations: 21     Fields:    Translation:Humans
  48. Andronesi OC, Ramadan S, Ratai EM, Jennings D, Mountford CE, Sorensen AG. Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners. J Magn Reson. 2010 Apr; 203(2):283-93. PMID: 20163975.
    Citations: 20     Fields:    
  49. Righi V, Andronesi O, Mintzopoulos D, Tzika AA. Molecular characterization and quantification using state of the art solid-state adiabatic TOBSY NMR in burn trauma. Int J Mol Med. 2009 Dec; 24(6):749-57. PMID: 19885614.
    Citations: 4     Fields:    Translation:AnimalsCells
  50. Sorensen AG, Jenning D, Wang M, Andronesi O, Chen P, Prados M, Wen P, Jackson E, Cha S, deGroot J. Use of neurovascular imaging in GBM patients (pts) to quantify early physiologic changes after treatment with XL184, an inhibitor of multiple receptor tyrosine kinases: Results from a phase II study. J Clin Oncol. 2009 May 20; 27(15_suppl):2048. PMID: 27964638.
    Citations:    
  51. Andronesi OC, Blekas KD, Mintzopoulos D, Astrakas L, Black PM, Tzika AA. Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers. Int J Oncol. 2008 Nov; 33(5):1017-25. PMID: 18949365.
    Citations: 6     Fields:    Translation:Humans
  52. Andronesi OC, Mintzopoulos D, Struppe J, Black PM, Tzika AA. Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy. J Magn Reson. 2008 Aug; 193(2):251-8. PMID: 18556227.
    Citations: 11     Fields:    
  53. Andronesi OC, von Bergen M, Biernat J, Seidel K, Griesinger C, Mandelkow E, Baldus M. Characterization of Alzheimer's-like paired helical filaments from the core domain of tau protein using solid-state NMR spectroscopy. J Am Chem Soc. 2008 May 07; 130(18):5922-8. PMID: 18386894.
    Citations: 36     Fields:    Translation:Cells
  54. Seidel K, Andronesi OC, Krebs J, Griesinger C, Young HS, Becker S, Baldus M. Structural characterization of Ca(2+)-ATPase-bound phospholamban in lipid bilayers by solid-state nuclear magnetic resonance (NMR) spectroscopy. Biochemistry. 2008 Apr 15; 47(15):4369-76. PMID: 18355039.
    Citations: 19     Fields:    Translation:Cells
  55. Tzika AA, Astrakas L, Cao H, Mintzopoulos D, Andronesi OC, Mindrinos M, Zhang J, Rahme LG, Blekas KD, Likas AC, Galatsanos NP, Carroll RS, Black PM. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med. 2007 Aug; 20(2):199-208. PMID: 17611638.
    Citations: 13     Fields:    Translation:Humans
  56. Etzkorn M, Martell S, Andronesi OC, Seidel K, Engelhard M, Baldus M. Secondary structure, dynamics, and topology of a seven-helix receptor in native membranes, studied by solid-state NMR spectroscopy. Angew Chem Int Ed Engl. 2007; 46(3):459-62. PMID: 17001715.
    Citations: 57     Fields:    Translation:Cells
  57. Hughes CE, Olejniczak S, Helinski J, Ciesielski W, Repisky M, Andronesi OC, Potrzebowski MJ, Baldus M. Probing structure in the polymorphic domain of the L-enantiomer of N-benzoyl-phenylalanine by means of 2D solid-state NMR spectroscopy and DFT calculations. J Phys Chem B. 2005 Dec 15; 109(49):23175-82. PMID: 16375280.
    Citations:    Fields:    Translation:Cells
  58. Heise H, Hoyer W, Becker S, Andronesi OC, Riedel D, Baldus M. Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc Natl Acad Sci U S A. 2005 Nov 01; 102(44):15871-6. PMID: 16247008.
    Citations: 170     Fields:    Translation:HumansCells
  59. Andronesi OC, Becker S, Seidel K, Heise H, Young HS, Baldus M. Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy. J Am Chem Soc. 2005 Sep 21; 127(37):12965-74. PMID: 16159291.
    Citations: 90     Fields:    Translation:Cells
  60. Andronesi OC, Pfeifer JR, Al-Momani L, Ozdirekcan S, Rijkers DT, Angerstein B, Luca S, Koert U, Killian JA, Baldus M. Probing membrane protein orientation and structure using fast magic-angle-spinning solid-state NMR. J Biomol NMR. 2004 Nov; 30(3):253-65. PMID: 15754053.
    Citations: 8     Fields:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Andronesi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (171)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.